Accumulating evidence has found that the Akt/GSK3β pathway can accelerate cell cycle progression in various types of tumours, and a previous study reported that Akt signalling could promote survival or inhibit apoptosis through substrates mediated in proportion by NF-κB [24]. Here, GSK3B is linked to neoplasm.